Should You Buy ASML Stock Before Jan. 28?

Aletheia Capital upgraded ASML from sell to buy and doubled its price target from $750 to $1,500, driving a roughly 9% jump on the first trading day of 2026 after the stock gained ~73% over the past year. Strong demand for advanced AI chips underpins ASML's outlook—TSMC is expected to raise 2026 capex toward ~$50 billion (vs $40–42 billion in 2025), WFE spending is forecast to rise 9% to $145 billion, and ASML reported order inflows of just under €4bn in Q1, €5.55bn in Q2 and €5.4bn in Q3—while consensus expects 28% EPS growth in 2025 and only ~6% revenue and earnings growth in 2026; ASML trades at ~34x forward earnings and will report Q4 2025 results on Jan. 28, 2026.

Analysis

Market structure: ASML is the primary winner as a near-monopoly supplier of EUV and >90% share in DUV, capturing disproportionate benefit from a WFE market projected to grow ~9% to $145B in 2026 and TSMC’s capex rising toward ~$50B. Beneficiaries also include advanced-node customers (TSM, NVDA, AAPL, AMD, QCOM) who rely on increased capacity; legacy-node suppliers and downstream OEMs with no access to EUV are the relative losers. The immediate effect is stronger pricing power, longer lead-times and stretched backlog (orders: ~€4B, €5.55B, €5.4B across 2025 quarters) which should support revenue recognition over multiple quarters.

Risk assessment: Tail risks include renewed export controls or China policy that cuts off a material addressable market, single-supplier execution problems with EUV yields/laser supply, or an AI demand slowdown that reverses capex — any of which could trim >20–30% revenue upside in 2026. Timewise, expect an immediate volatility bump around Jan 28 Q4 results, short-term booking/backlog revelations over next 3 months, and multi-quarter revenue recognition through 2026–2028. Hidden dependencies: customer concentration (large share of orders tied to TSMC/Nvidia), FX (EUR/USD swings on margins), and supplier bottlenecks for optical components.

Trade implications: Establish a tactical long ASML position (2–3% portfolio) in two tranches: 50% pre-earnings and add on pullback >10% within 30 days; target total return +25% over 6–12 months, stop-loss at -12%. Consider a pairs trade: long ASML vs short high-beta semiconductor ETF (e.g., SOXX) sized 1:1 notional to isolate equipment vs product cyclicality. Options: buy a Jan 31, 2026 call spread (OTM debit) sized to risk 0.5–1% of portfolio into the Jan 28 catalyst to cap downside cost while retaining upside.

Contrarian angles: Consensus may overstate perpetual AI-driven capex — backlog could be front-loaded and revenue recognition delayed, so forward P/E 34 already embeds a strong beat; upside is therefore not free. If ASML stock rallies >20% without commensurate bookings/shipments, probability of mean reversion rises; historical analogs: prior equipment cycles (2017–18) saw rapid multiple contraction after inventory-normalization. Unintended consequence: extreme concentration in ASML could increase portfolio volatility if geopolitical fragmentation accelerates, so cap exposure accordingly.

Key Decisions for Investors

• Establish a 2–3% long position in ASML (NASDAQ: ASML) in two tranches: 50% immediately and 50% on any pullback ≥10% within the next 30 days; set a tactical stop-loss at −12% and target +25% over 6–12 months, reassess after Q4 results on Jan 28, 2026.
• Buy a limited-risk options trade into the Jan 28, 2026 earnings catalyst: purchase an OTM call spread (expiry ~Jan 31, 2026) sized to risk 0.5–1% of portfolio to capture an upside beat while capping premium spend.
• Implement a pair trade to hedge end-market cyclicality: long ASML vs short 1.0x notional of SOXX (or equivalent semiconductors ETF) to express equipment outperformance vs product-level cyclicality; rebalance if spread widens >15% or after ASML confirms multi-quarter shipment cadence.
• Reduce exposure to high-multiple, consumer-facing chip names by 2–4% (e.g., trim NVDA/AAPL sized positions) if ASML’s forward multiple expands >40x or ASML stock gains >20% without commensurate bookings; redeploy proceeds to ASML or cash.